The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Tessari Eben

Reporting owner CIK 0001867899 · CHIEF OPERATING OFFICER

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Tessari EbenTessari EbenTessari Eben · December 15, 2025 · Exercise / conversion · Class A Ordinary ShareTessari Eben · November 26, 2025 · Exercise / conversion · Class A Ordinary ShareTessari Eben · November 17, 2025 · Exercise / conversion · Class A Ordinary ShareTessari Eben · October 14, 2025 · Exercise / conversion · Class A Ordinary ShareOct 14, 2025Dec 15, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 15, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareTessari EbenExercise / conversion
Nov 26, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareTessari EbenExercise / conversion
Nov 17, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareTessari EbenExercise / conversion
Oct 14, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareTessari EbenExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M6,0008.83Value: 52,980Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M20022.89Value: 4,578Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M6,5008.83Value: 57,395Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Tessari EbenCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M6,5008.83Value: 57,395Currency not specifiedView ↗